Sökresultat

Filtyp

Din sökning på "*" gav 567258 sökträffar

ECT more effective than ketamine in severe depression

Researchers at Lund University in Sweden have compared the effects of intravenous ketamine treatment with ECT treatment in severe depression. The results support the view that ketamine is a possible treatment, but also show that ECT treatment helps more people. In recent years, ketamine has emerged as a new treatment for depression, after studies have shown it to be a fast-acting antidepressant. “

https://www.medicine.lu.se/article/ect-more-effective-ketamine-severe-depression - 2026-07-13

New research highlights genetic differences between different forms of type 2 diabetes

Previous research from Lund University has shown that diabetes can be divided into five groups with different disease progression. A new study published in Nature Genetics demonstrates that there are also genetic differences between different groups of patients. An important goal of the research is to contribute with knowledge that will enable tailored treatments of patients with type 2 diabetes.

https://www.medicine.lu.se/article/new-research-highlights-genetic-differences-between-different-forms-type-2-diabetes - 2026-07-13

Bread study examines the role of genes in breaking down food

A lot of research explains which diets may reduce the risk of developing type 2 diabetes. Much research remains to be done about how our genes respond to the foods we eat. A new study led by researchers at Lund University adds to evidence that variations in the AMY1 gene may affect the way the body breaks down starchy foods. Unhealthy food habits are risk factors for developing type 2 diabetes. An

https://www.medicine.lu.se/article/bread-study-examines-role-genes-breaking-down-food - 2026-07-13

Hello Professor Tomas Deierborg, and congratulations on the considerable international attention attracted by your study...

...showing that competitors in the Vasaloppet cross-country ski race run a lower risk of suffering from anxiety than the general population. Your results have been reported by the New York Times, CNN and many other international news outlets. Published in September last year, the article Physical Activity Is Associated With Lower Long-Term Incidence of Anxiety in a Population-Based, Large-Scale St

https://www.medicine.lu.se/article/hello-professor-tomas-deierborg-and-congratulations-considerable-international-attention-attracted - 2026-07-13

New therapies for ITP

Immune Thrombocytopenia, ITP, is an autoimmune bleeding disorder that is still treated with immunosuppressive drugs that cause serious side effects. Professor John Semple’s laboratory studies the pathophysiological mechanisms behind this disease and together with Dr. Drew Provan, London, UK, has recently published the newest ideas on pathological mechanisms and therapies for the treatment and mana

https://www.medicine.lu.se/article/new-therapies-itp - 2026-07-13

A new multipurpose on-off switch for inhibiting bacterial growth

Researchers in Lund have discovered an antitoxin mechanism that seems to be able to neutralise hundreds of different toxins and may protect bacteria against virus attacks. The mechanism has been named Panacea, after the Greek goddess of medicine whose name has become synonymous with universal cure. The understanding of bacterial toxin and antitoxin mechanisms will be crucial for the future success

https://www.medicine.lu.se/article/new-multipurpose-switch-inhibiting-bacterial-growth - 2026-07-13

New precision technology for immunotherapy

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still significant challenges in the identification of cancer cell surface proteins as targets for immunotherapies. A research group

https://www.medicine.lu.se/article/new-precision-technology-immunotherapy - 2026-07-13

81 million SEK drives new international effort to study aging and epigenetic changes in Parkinson’s Disease

Every person ages, yet only some develop Parkinson’s Disease, and scientists still don’t know why. A new international effort involving a research team from Lund University aims to uncover what makes certain aging brains more vulnerable than others, focusing on the epigenetic changes that accompany growing older. Their work is supported by a new 81 million SEK grant from the Aligning Science Acros

https://www.stemcellcenter.lu.se/article/81-million-sek-drives-new-international-effort-study-aging-and-epigenetic-changes-parkinsons-disease - 2026-07-13

Early-life B cells can drive leukemia later in life

Researchers at the Lund Stem Cell Center, Lund University, have discovered that a population of B cells formed shortly after birth store long-term immune memory and, in mice, can give rise to leukemia much later in life. Published in Cell Reports, the findings reveal how immune events at the very beginning of life can leave lasting biological imprints, linking early development to disease in old a

https://www.stemcellcenter.lu.se/article/early-life-b-cells-can-drive-leukemia-later-life - 2026-07-13

Lund Stem Cell Center joins BEYOND European postdoctoral programme in advanced therapies

The Lund Stem Cell Center at Lund University is a partner in BEYOND, a new European postdoctoral training programme designed to prepare the next generation of researchers in advanced cell and gene therapies. Coordinated by Fondazione Telethon, the programme is supported by €6 million from the Horizon Europe Marie Skłodowska Curie Actions (MSCA) COFUND scheme and will fund 35 international postdoct

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-joins-beyond-european-postdoctoral-programme-advanced-therapies - 2026-07-13

STEM-PD enters a new chapter as Cellular Intelligence acquires global rights to advance the stem cell therapy for Parkinson's Disease

The STEM PD clinical trial, a stem cell–based approach for Parkinson’s disease, is entering a new phase in its development. In May 2026, Cellular Intelligence, an AI native biotech company, announced that it has acquired global rights from the Danish pharmaceutical company, Novo Nordisk, to further advance the clinical development of the STEM PD programme. STEM‑PD is among a small number of plurip

https://www.stemcellcenter.lu.se/article/stem-pd-enters-new-chapter-cellular-intelligence-acquires-global-rights-advance-stem-cell-therapy - 2026-07-13

A training ground for cell and gene therapies: New pre-GMP facility aims to smooth the path from idea to patient

When research findings are ready to make the leap from the lab to the patient, the requirements become much stricter. That is precisely where many promising projects start to falter. “We want to be the bridge between research and the patient, so that promising projects don’t get stuck in that difficult transition,” says Sara Nolbrant, director of the new pre-GMP facility. And with that, she disapp

https://www.stemcellcenter.lu.se/article/training-ground-cell-and-gene-therapies-new-pre-gmp-facility-aims-smooth-path-idea-patient - 2026-07-13

Lund Stem Cell Center welcomes four new research group leaders

Lund Stem Cell Center continues to grow as a leading hub for interdisciplinary stem cell research, welcoming four new principal investigators into its research community. Together, they bring specialised expertise spanning molecular and cell biology, immunology and bioengineering, further strengthening the Center’s scientific scope and possibilities for collaboration. How cells protect their DNA,

https://www.stemcellcenter.lu.se/article/lund-stem-cell-center-welcomes-four-new-research-group-leaders - 2026-07-13

STEM-PD announces first in-human clinical trial results for Parkinson’s disease cell therapy

A landmark study led from Lund, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects linked to the transplanted cells were seen during the first year of follow up. The results are published in Nature Medicine. In Parkinson’s disease, patients lose nerve cells in

https://www.stemcellcenter.lu.se/article/stem-pd-announces-first-human-clinical-trial-results-parkinsons-disease-cell-therapy - 2026-07-13

Welcome two new Principal Investigators to Lund Stem Cell Center

This article is over 5 years old, and the information may therefore be outdated. Principal Investigators Daniella Ottosson and Charlotta Böiers have been accepted to join Lund Stem Cell Center.A warm welcome to the Ottosson and Böiers groups. To learn more about their research, the following Stem Cell Talks have been scheduled: Wednesday 25th September: Principal Investigator Daniella Ottosson. De

https://www.stemcellcenter.lu.se/article/welcome-two-new-principal-investigators-lund-stem-cell-center - 2026-07-13

Jonna Pettersson has defended her thesis

This article is over 5 years old, and the information may therefore be outdated. Jonna Pettersson defended her dissertation "Incalculable Community" today at one o'clock in Edens Hörsal, The Department of Political Science, Lund. External reviewer: Associate professor Lars Toender, University of Melbourne.Jonna Pettersson  AbstractThis thesis argues that the Western thinking of political community

https://www.svet.lu.se/en/article/jonna-pettersson-has-defended-her-thesis - 2026-07-13

Spring conference SNES

This article is over 5 years old, and the information may therefore be outdated. The Swedish Network for European Studies in Political Science is organising its spring conference in Stockholm 19-20 March 2015. This year's theme is: Change and Continuity in Transatlantic Relations.

 SNES Spring Conference 2015

https://www.svet.lu.se/en/article/spring-conference-snes - 2026-07-13

Elgström och Skovgaard: Climate Change Negotiations

This article is over 5 years old, and the information may therefore be outdated. NEW FROM OUR RESEARCHERS: Ole Elgström and Jakob Skovgaard have penned the article "Previewing Paris 2015: The EU's ‘Leadiator’ Role in Future Climate Change Negotiations" published in the Georgetown Journal of International Affairs Online, "the flagship publication of Georgetown's School of Foreign Service".Together

https://www.svet.lu.se/en/article/elgstrom-och-skovgaard-climate-change-negotiations - 2026-07-13